価格表

在庫・価格 : 2026年04月06日 21時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TRANCE/TNFSF11/RANK L, Mouse-Mono(12A668)
データシート※最新のデータシートでない場合があります
NB100-56593SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥50,000
(未発注)
追加

在庫・価格 : 2026年04月06日 21時32分 現在

Anti-TRANCE/TNFSF11/RANK L, Mouse-Mono(12A668)

  • 商品コード:NB100-56593SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥50,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Fiumara P et al. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 2001 Nov;98(9):2784-90
Fiumara P et al
2001/01/01
Applications: PubMed
2 Pearse RN et al. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. U.S.A. 2001 Sep;98(20):11581-6
Pearse RN et al
2001/01/01
Applications: PubMed
3 Parrula C et al. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. Vet. Pathol. 2009 Sep;46(5):1003-14
Parrula C et al
2009/01/01
Applications: PubMed
4 Hsu H et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. U.S.A. 1999 Mar;96(7):3540-5
Hsu H et al
1999/01/01
Applications: PubMed
5 Kikuchi T et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 2001 Mar;166(5):3574-9
Kikuchi T et al
2001/01/01
Applications: PubMed
6 Shin M et al. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis 2011 Nov;32(11):1634-40
Shin M et al
2011/01/01
Applications: PubMed
7 Sandra F et al. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol. 2005 Jul;41(6):637-44
Sandra F et al
2005/01/01
PubMed
8 Ghoreishi M et al. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J. Immunol. 2009 May;182(10):6071-8
Ghoreishi M et al
2009/01/01
PubMed
9 Hu P et al. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS ONE 2011;6(12):e28670
Hu P et al
2011/01/01
PubMed
10 Rubin J et al. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Prostate 2004 Jan;58(1):41-9
Rubin J et al
2004/01/01
PubMed
  • No.: 1
  • 文献情報:
    Fiumara P et al. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 2001 Nov;98(9):2784-90
    Fiumara P et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Pearse RN et al. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. U.S.A. 2001 Sep;98(20):11581-6
    Pearse RN et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Parrula C et al. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. Vet. Pathol. 2009 Sep;46(5):1003-14
    Parrula C et al
    2009/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Hsu H et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. U.S.A. 1999 Mar;96(7):3540-5
    Hsu H et al
    1999/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Kikuchi T et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 2001 Mar;166(5):3574-9
    Kikuchi T et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Shin M et al. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis 2011 Nov;32(11):1634-40
    Shin M et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Sandra F et al. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol. 2005 Jul;41(6):637-44
    Sandra F et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Ghoreishi M et al. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J. Immunol. 2009 May;182(10):6071-8
    Ghoreishi M et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Hu P et al. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS ONE 2011;6(12):e28670
    Hu P et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Rubin J et al. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Prostate 2004 Jan;58(1):41-9
    Rubin J et al
    2004/01/01
  • 備考:
  • 参照:
    PubMed